ANNX
#2511
Annexon, Inc. - common stock
5.8 2 USD
+0.05%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+4.86%
Variación mensual
+25.43%
Variación en los últimos 6 meses
-6.13%
Cambio anual
+130.95%
Cierres anteriores
5.5 5
Open
5.5 9
Mínimo
5.5 9
High
5.8 2
Volumen
965
Financials
- Market Capitalization 953.56 M
- Employee 93
- Founded 2011
- CEO N/A
- Website www.annexonbio.com
- Headquarter Delaware, United States
- FIGI BBG007QVDFG2
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2494 |  AVTX Avalo Therapeutics, Inc. - Common Stock | 18.47 USD | +0.27% | +0.49% | +26.59% | +280.82% | 970.89 M USD | ||
| 2507 |  JANX Janux Therapeutics, Inc. - Common Stock | 15.69 USD | -0.57% | -2.91% | +13.94% | -39.72% | 956.84 M USD | ||
| 2514 |  ANRO Alto Neuroscience, Inc. Common Stock | 27.04 USD | -2.87% | +9.92% | +24.72% | +944.02% | 948.94 M USD | ||
| 2523 |  PHAR Pharming Group N.V. - ADS, each representing 10 | 13.39 USD | -0.22% | -7.91% | +4.94% | +34.03% | 939.55 M USD |